Lupin Limited — Updates, 20-05-2025: Press Release

Lupin has announced a board meeting to discuss the financial results for the quarter and half-year. The company is integrating Honeywell’s low global warming potential Solstice® Air propellant in its respiratory inhalers, aiming to lead sustainable innovation in asthma and COPD treatments. This eco-friendly tech could cut carbon emissions by up to 99.9%, strengthening Lupin’s respiratory portfolio with next-gen inhalers and boosting its green credentials.